parietaria judaica pollen extract
Allergenexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2008 (NCT00916760)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetImmunity, desensitized
immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- depigoid parietaria judaica
- parietaria judaica pollen extract
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02477917 | Phase 1 | May 1, 2015 | Roxall Medizin |
| NCT00916760 | Phase 3 | Feb 1, 2008 | Hospital Vega Baja, Leti Pharma GmbH |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hospital Vega Baja | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Leti Pharma GmbH | For profit | 1 | 1 | 1 | 2008 |
| Roxall Medizin | For profit | 1 | 1 | 1 | 2015 |
3 organizations
Page 1 / 1